Proteomika, SL

Proteomika was established in 2002 with the objective of becoming a leader company in the Proteomics field. Proteomika has established research collaborations with pharmaceutical and biotechnological companies aimed at the discovery and validation of non-invasive diagnosis and pharmacoproteomics markers and at the discovery of therapeutic targets and new drugs directed against them.

Activity:

- Contract Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Preventive
- Proteins
- Technology

Therapeutic targets:

- Alzheimer's Disease
- Cancer
- Cardiovascular
- Central nervous system
- Genetics
- Neurology
- Oncology

Markets Covered

a. HeadQuarter: Spain

b. Continent(s) active: Europe

c. Countries active: Spain, France, Germany, UK

Corporate data:

Number of Employees: 20

Turnover:

Amount:	Year:	Currency:
n/a	2002	Euro

Year founded: 2002